Open AccessNIVOLUMAB IN THE TREATMENT OF REFRACTORY RECURRENT AND METАSTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA. THE RESULTS OF A PHASE III CLINICAL TRIAL (CHECKMATE 141)
Author(s) -
А. М. Мудунов
Publication year - 2017
Publication title -
opuholi golovy i šei
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.14
H-Index - 1
eISSN - 2411-4634
pISSN - 2222-1468
DOI - 10.17650/2222-1468-2017-7-3-74-86
Subject(s) - nivolumab , medicine , oncology , head and neck squamous cell carcinoma , head and neck cancer , radiation therapy , immunotherapy , refractory (planetary science) , cancer , clinical trial , physics , astrobiology